Moderate hypofractionation is the standard of care for adjuvant whole-breast radiotherapy
after breast-conserving surgery for breast cancer. Recently, 10-year results from the FAST …

As the global COVID-19 pandemic escalates there is a need within radiation oncology to
work to support our patients in the best way possible. Measures are required to reduce …

Breast cancer is the most common cancer diagnosed among women worldwide and more
than half are diagnosed above the age of 60 years. Life expectancy is increasing and the …

Background Male breast cancer (MBC) is a rare disease for which there is limited
understanding of treatment patterns and prognostic factors. Methods Men with TNM stage I …

The systemic immune‐inflammation index (SII= N× P/L) based on neutrophil (N), platelet (P)
and lymphocyte (L) counts is used to predict the survival of patients with malignant tumours …

Background The number of elderly patients diagnosed with breast cancer is increasing
worldwide. However, treatment decisions for these patients are highly variable. Although …

Background: The ability to account for comorbidity when estimating survival in a population
diagnosed with cancer could be improved by using a drug comorbidity index based on filled …

The past two decades have seen an unprecedented trend towards de-escalation of surgical
therapy in the setting of early BC, the most prominent examples being the reduction of re …

The COVID-19 pandemic poses a barrier to equal and evidence-based management of
cancer in older adults. The International Society of Geriatric Oncology (SIOG) formed a panel …

Purpose/objective Adjuvant whole breast radiotherapy and systemic therapy are part of the
current evidence-based treatment protocols for early breast cancer, after breast-conserving …